About AGIOS PHARMACEUTICALS, INC.
Agios is a biopharmaceutical company focused on developing therapies for rare diseases, particularly hemolytic anemias, with a near-term emphasis on thalassemia and sickle cell disease. The company emphasizes patient-centric approaches and partnerships to drive scientific innovation.
Development of therapies for rare diseasesFocus on hemolytic anemias, including thalassemia and sickle cell diseaseClinical trials for lead product candidates such as mitapivat and AG-946Collaboration with patient communities and healthcare professionals
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AGIOS PHARMACEUTICALS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.